Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for iBio (IBIO) over the last 17 years, with Q3 2025 value amounting to 5735.0%.

  • iBio's EBITDA Margin changed N/A to 5735.0% in Q3 2025 from the same period last year, while for Dec 2025 it was 8260.0%, marking a year-over-year decrease of 41565300.0%. This contributed to the annual value of 4650.5% for FY2025, which is 27423900.0% up from last year.
  • Per iBio's latest filing, its EBITDA Margin stood at 5735.0% for Q3 2025.
  • In the past 5 years, iBio's EBITDA Margin registered a high of 377.11% during Q1 2022, and its lowest value of 10206.0% during Q3 2023.
  • Its 5-year average for EBITDA Margin is 3570.15%, with a median of 2182.0% in 2024.
  • Data for iBio's EBITDA Margin shows a peak YoY increase of 32917600bps (in 2021) and a maximum YoY decrease of -45314600bps (in 2021) over the last 5 years.
  • iBio's EBITDA Margin (Quarter) stood at 6220.24% in 2021, then soared by 94bps to 377.11% in 2022, then crashed by -2606bps to 10206.0% in 2023, then soared by 79bps to 2182.0% in 2024, then tumbled by -163bps to 5735.0% in 2025.
  • Its last three reported values are 5735.0% in Q3 2025, 2599.0% for Q2 2025, and 2182.0% during Q4 2024.